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Abstract
Introduction: Failure of sputum smear and/or culture conversion after 2 months of tuberculosis
(TB) treatment has been considered a predictor of patient infectivity and treatment failure.
We aimed to identify the factors associated with delayed sputum smear and culture conversion
in patients with pulmonary TB who were given anti-TB treatment.
Material and methods: Retrospective cohort of 136 adult patients with sputum culture-proven
pulmonary TB referred to an urban Chest Disease Centre. Socio-demographic, clinical, radio-
logical, microbiological, and therapeutic data were evaluated.
Results: The median age was 41.0 (interquartile range [IQR] 18.0) years and 75.0% of patients
were male. Delayed sputum smear and culture conversion occurred in 25.4% (30/118) and 27.2%
(37/136) of patients, respectively. Multivariate analysis indicated that age≥ 50 years (odds ratio
[OR] 4.4, 95% conﬁdence interval [CI] 1.5--13.3), male gender (OR 10.8, 95% CI 1.3--91.1), and
smear grade > 1--9 acid fast bacilli (AFB)/ﬁeld (3+) (OR 11.7, 95% CI 1.4--100.6) were signiﬁcantly
associated with persistent smear positivity after 2 months of treatment. Bilateral radiological
involvement (OR 3.7, 95% CI 1.5--9.0) and colony count > 100 (3+) (OR 5.8, 95% CI 1.2--27.4)
were signiﬁcantly associated with persistent culture positivity.
Conclusions: Delayed sputum smear and culture conversion occurred in about one third of
patients. Older age, male gender, and higher bacillary load were independently associated
with delayed smear conversion. Bilateral radiological involvement and higher colony count were
ith delayed culture conversion.independently associated w
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Preditores de conversão tardia dos exames micobacteriológicos direto e cultural de
expetorac¸ão numa populac¸ão portuguesa com tuberculose pulmonar
Resumo
Introduc¸ão: A ausência de conversão dos exames micobacteriológicos direto e/ou cultural de
expetorac¸ão após 2 meses de tratamento para a tuberculose (TB) tem sido considerado um
preditor do grau de infeciosidade do doente e de falência terapêutica. Os autores estabeleceram
por objetivo a identiﬁcac¸ão dos fatores associados com a conversão tardia dos exames direto e
cultural de expetorac¸ão num grupo de doentes com TB pulmonar sob tratamento antibacilar.
Material e métodos: Coorte retrospetiva de 136 doentes adultos com TB pulmonar, conﬁrmada
por exame cultural de expetorac¸ão, referenciados a um Centro de Diagnóstico Pneumológico
urbano. Foram analisadas variáveis sócio-demográﬁcas, clínicas, radiológicas, microbiológicas
e relacionadas com a terapêutica.
Resultados: A mediana de idades foi 41,0 (intervalo interquartil [IIQ] 18,0) anos e 75,0% dos
doentes eram do género masculino. A conversão tardia dos exames de expetorac¸ão direto
e cultural ocorreu em 25,4% (30/118) e 27,2% (37/136) dos doentes, respetivamente. Pela
análise multivariada, a idade≥ 50 anos (odds ratio [OR] 4,4, intervalo de conﬁanc¸a [IC] 95%
1,5--13,3), o género masculino (OR 10,8, IC 95% 1,3--91,1), e a carga bacilar > 1--9 bacilos álcool-
ácido resistentes (BAAR)/campo (3+) (OR 11,7, IC 95% 1,4--100,6) estiveram signiﬁcativamente
associados com a positividade persistente do exame direto, após 2 meses de tratamento. O
envolvimento radiológico bilateral (OR 3,7, IC 95% 1,5--9,0) e a contagem de colónias > 100
(3+) (OR 5,8, IC 95% 1,2--27,4) estiveram signiﬁcativamente associados com a positividade
persistente do exame cultural.
Conclusões: A conversão tardia dos exames direto e cultural de expetorac¸ão ocorreu em cerca
de um terc¸o dos doentes. A idade mais avanc¸ada, o género masculino e a elevada carga
bacilar estiveram independentemente associados com a conversão tardia do exame direto
de expetorac¸ão. O envolvimento radiológico bilateral e a contagem de colónias mais elevada
estiveram independentemente associados com a conversão tardia do exame cultural.
© 2011 Sociedade Portuguesa de Pneumologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
s
t
f
m
i
r
a
h
r
a
e
d
s
t
a
s
c
t
t
s
e
l
fIntroduction
Successful control of tuberculosis (TB) depends on early and
effective prevention of the transmission of Mycobacterium
tuberculosis (MT) from infectious patients. Sputum steril-
ization is a cardinal index of treatment success and low
patient infectivity, and is used to establish the time for
airborne isolation in outpatient and inpatient settings. In
countries with greater resources, documentation of culture
conversion is currently recommended before completion
of anti-TB treatment.1,2 Despite the discordance between
smear results and culture results (described below), smear
microscopy is faster, simpler, and less expensive than cul-
turing, and has thus been widely used for diagnosis and
treatment in resource-limited areas.1
Some studies reported that the number of acid-fast
bacilli (AFB) decreases rapidly after starting treatment and
that 80--85% of TB patients become non-infectious after
about 2 weeks.3--5 However, Wang et al.6 estimated that
more than 50% of TB patients probably remained infectious
after 2 weeks of treatment. This highlights the impor-
tance of regular smear and culture monitoring until three
consecutive samples are negative in order to establish
the time needed for respiratory isolation and to provide
proper protection for uninfected contacts. This issue had
been previously noted by Clancy.7 Epidemiological studies
indicated that the proportion of TB patients who remain
s
e
v
tmear-positive after 2 months of treatment can be greater
han 20% (3.3--25.3%).6--13 Other evidence indicates that
ailure of smear and/or culture conversion in the second
onth of TB treatment is a predictor of patient infectiv-
ty and treatment failure.6,8--11,14 Thus, identiﬁcation of the
isk factors is very important for TB control policies and for
llocation of public health resources. Several studies6,13,15--18
ave reported that male gender, diabetes mellitus, smoking,
adiologically extensive disease, cavitation, smear grade,
nd other factors increase the risk for TB infectivity. How-
ver, some of the results of these studies were inconsistent
ue to differences in methodologies, such as the use of
mear conversion rather than culture conversion. In par-
icular, previous research has indicated that there can be
discordance between 2-month smear and culture conver-
ion results, and that up to 30% of TB patients who become
ulture-negative remain smear-positive.19--21 This is due to
he presence of nonviable AFB, nontuberculous mycobac-
eria colonization, or false-positive results.19--21 A recent
ystematic review and meta-analysis performed by Horne
t al. concluded that both smear and culture methods have
ow sensitivity and speciﬁcity for prediction of treatment
ailure and relapse.22 This position has been argued by
ome23 in relation to issues concerning methodology, how-
ver, Su et al. demonstrated that the limited predictive
alue of the 2-month smear in culture conversion was due
o the signiﬁcant impact of some clinical factors, beyond
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mear status, such as cavitation, rifampicin resistance, and
se of a directly observed therapy (DOT) strategy.24
The disappearance of AFB from smears and cultures is
he most widely accepted determinant for establishing the
ength of isolation and treatment of patients with pulmonary
B, although caution and clinical judgment must be used
n the interpretation of these results, mainly in relation to
mear interpretation. The present study was carried out to
etermine the time to smear and culture conversion and to
dentify potential predictors for delayed smear and culture
onversion in patients with pulmonary TB.
aterial and methods
tudy design and population
etrospective cohort of adult patients with sputum culture-
roven pulmonary TB who were referred to an urban Chest
isease Centre (Vila Nova de Gaia, Portugal), from January
006 to June 2009.
Socio-demographic, clinical, microbiological, radiologi-
al, and therapeutic data were collected from patients’ ﬁles
nd the National Plan Against Tuberculosis databases.
The exclusion criteria were: multidrug resistance,
nability to collect sputum, default, transfer to another
nstitution, or death during treatment.
ycobacterial examinations -- sputum smear and
ulture
putum smears were examined for AFB by ﬂuorescence
icroscopy and/or Ziehl--Neelsen staining and graded by
tandard criteria and equivalent: 1--9 AFB/100 ﬁelds (1+);
--9 AFB/10 ﬁelds (2+); 1--9 AFB/ﬁeld (3+); and >9 AFB/ﬁeld
4+).25,26
Specimens were cultured on the liquid medium
ACTEC MGIT 960 (Becton Dickinson) and/or on the
owenstein--Jensen solid medium (Bio-Rad) and graded as
ollows: <10 colonies (1+); 10--100 colonies (2+); >100
olonies (3+); and conﬂuence (4+), according to reference
aboratory criteria. All ﬁrst-positive culture examinations
ere subjected to MT identiﬁcation tests and drug sus-
eptibility tests (DST) (minimal inhibitory concentration
ethod).
adiology ﬁndings
hest X-rays were characterized according to extension (uni-
ateral, bilateral) and cavitation.
reatment and monitoring
6-month standard treatment based on international
onsensus1 was used (initial phase (2 months): daily isoniazid
H), rifampicin (R), pyrazinamide (Z), and ethambutol (E);
ontinuance phase (4 months): daily H and R), and changed
or patients with concomitant hepatic and/or renal diseases,
dverse effects, and DST results. A DOT was given for the
ntire course of all treatments. Smear and culture examina-
ions were performed at the beginning, at 2 months, and at
he end of treatment. However, smears were taken every 2
w
p
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eeks until there were 3 consecutive negative samples and
ulture examinations were taken every month until there
ere 2 consecutive negative samples.27
eﬁnitions
mear conversion was deﬁned as 3 consecutive negative
amples. Smear and culture conversion time was calculated
rom the beginning of treatment to the date of the ﬁrst
egative sample. Delayed smear and culture conversion was
eﬁned as persistent positivity after 2 months of treatment.
tatistical analysis
tatistical analysis was performed using the SPSS version
7.0 software (SPSS Inc., Chicago, Illinois, USA). All prob-
bilities were two-tailed and p values < 0.05 were regarded
s signiﬁcant.
Data were described as median and interquartile range
IQR) for quantitative variables (non-normally distributed)
nd as counts and proportions for qualitative variables. For
omparison of quantitative variables the Mann--Whitney test
as used. The Chi-square test or the Fisher exact test was
sed to compare categorical variables whenever was appro-
riate.
Delayed smear and culture conversion was a dichoto-
ous dependent variable. Variables that were statistically
igniﬁcant and biologically plausible in univariate analysis
ere entered into a logistic regression model with forward
tepwise conditional in order to identify the factors indepen-
ently associated with that outcome. The odds ratios (OR)
nd 95% conﬁdence intervals (CI) were determined.
esults
total of 136 patients were retrospectively enrolled. The
edian age was 41.0 (IQR 18.0) years, and 75.0% of the
atients were male. Table 1 shows the socio-demographic
haracteristics and comorbidities of enrolled patients at
aseline. All patients had sputum culture-proven pulmonary
B and 118 patients (86.8%) were smear-positive.
Median smear and culture conversion time was 46 (range
--343) days and 46 (range 1--127) days, respectively. After 2
onths of treatment, 25.4% (30/118) and 27.2% (37/136) of
atients remained smear- and culture-positive, respectively.
mong the 30 patients with delayed smear conversion, 6
chieved culture conversion. Table 2 shows other charac-
eristics of TB in the enrolled patients.
actors associated with smear conversion
ale gender [55.0 (IQR 53.0) days vs 34.0 (IQR 24.5) days;
= 0.028], current smoking habits [54.0 (IQR 48.0) days vs
8.0 (IQR 33.5) days; p = 0.004], and higher smear gradings
1+: 24.0 (IQR 14.0) days vs 2+: 35.0 (IQR 36.3) days vs 3+:
3.0 (IQR 54.5) days vs 4+: 62.0 (IQR 62.5) days; p = 0.001]
ere associated with longer smear conversion time.
Univariate analysis indicated that the risk of a persistent
ositive smear at 2 months was greater in patients who were
50 years, male, and had a bacillary load >3+ (Table 3).
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Table 1 Socio-demographic characteristics and comorbidi-
ties of baseline population.
Characteristics All patients (n = 136)
Age (years) 41.0 (IQR 18.0)
Gender, n (%)
Female/male 34 (25.0)/102 (75.0)
Unemployment, n (%)
Yes/no 50 (36.8)/86 (63.2)
Immigrants, n (%)
Yes/no 6 (4.4)/130 (95.6)
Reclusion, n (%)
Yes/no 2 (1.5)/134 (98.5)
Homeless, n (%)
Yes/no 6 (4.4)/130 (95.6)
Community residence, n (%)
Yes/no 3 (2.2)/133 (97.8)
Current smoking habits, n (%)
Yes/no 75 (72.8)/28 (27.2)
Alcohol habits, n (%)
Yes/no 21 (15.4)/115 (84.6)
Drug users, n (%)
Yes/no 15 (11.0)/121 (89.0)
HIV positivity, n (%)
Yes/no 15 (11.0)/121 (89.0)
DM, n (%)
Yes/no 10 (7.4)/126 (92.6)
Neoplastic disease, n (%)
Yes/no 5 (3.7)/131 (96.3)
Previous TB, n (%)
Yes/no 12 (8.8)/124 (91.2)
Weight, n (%)
<60 kg/≥60 kg 72 (57.1)/54 (42.9)
Quantitative variables are expressed as median and interquartile
Table 2 TB features and treatment.
Characteristics All patients (n = 136)
Pulmonary/extra-pulmonary
TB, n (%)
128 (94.1)/8 (5.9)
Radiological involvement, n (%)
Unilateral/bilateral 79 (61.2)/50 (38.8)
Cavitation, n (%)
Yes/no 92 (67.6)/44 (32.4)
Smear grading, n (%)
1--9 AFB/100 ﬁelds (1+) 6 (6.5)
1--9 AFB/10 ﬁelds (2+) 14 (15.0)
1--9 AFB/ﬁeld (3+) 24 (25.8)
>9 AFB/ﬁeld (4+) 49 (52.7)
Culture grading, n (%)
<10 colonies (1+) 8 (7.3)
10--100 (2+) 15 (13.8)
>100 (3+) 27 (24.8)
Conﬂuence (4+) 59 (54.1)
Drug susceptibility test, n (%)
Sensitive 126 (92.7)
Isoniazide resistance 1 (0.7)
Streptomycin resistance 7 (5.1)
Isoniazid and streptomycin
resistance
2 (1.5)
Treatment toxicity, n (%)
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HIV: human immunodeﬁciency virus; DM: diabetes mellitus; TB:
tuberculosis.
There were no statistically signiﬁcant differences in other
evaluated variables, such as immigrant status, reclusion,
homelessness, community residence, alcohol habit, drug
abuse, diabetes mellitus, neoplastic disease, previous TB,
disease extension (pulmonary or extra-pulmonary), alterna-
tive anti-TB treatment, and related toxicity.
Multivariate logistic regression analysis indicated that all
3 signiﬁcant variables from the univariate analysis were
independently associated with delayed smear conversion
(age≥ 50 years: OR 4.4, 95% CI 1.5--13.3; male gender: OR
10.8, 95% CI 1.3--91.1; bacillary load > 3+: OR 11.7, 95% CI
1.4--100.6) (Table 4).Factors associated with culture conversion
Unemployment [56.0 (IQR 55.0) days vs 41.5 (IQR 46.3)
days; p = 0.046], current smoking habits [58.0 (IQR 47.0)
a
m
oYes/no 17 (14.4)/101 (85.6)
TB: tuberculosis; AFB: acid fast bacilli.
ays vs 33.5 (IQR 40.3) days; p = 0.022], bilateral radiological
nvolvement [59.5 (IQR 64.8) days vs 41.0 (IQR 43.0) days;
= 0.011], cavitary disease [57.0 (IQR 49.8) days vs 35.0 (IQR
2.3) days; p = 0.006], and higher colony count [1+: 20.5 (IQR
8.5) days vs 2+: 27.0 (IQR 26.0) days vs 3+: 39.0 (IQR 33.0)
ays vs 4+: 66.0 (IQR 54.0) days; p < 0.001] were associated
ith longer culture conversion time.
Univariate analysis indicated that the risk of a persis-
ent positive culture at 2 months was greater in patients
ho were unemployed, HIV-positive, had bilateral radiolog-
cal involvement, had cavitary disease, and had a colony
ount > 3+ (Table 3).
Multivariate logistic regression analysis indicated that
nly bilateral radiological involvement (OR 3.7, 95% CI
.5--9.0) and colony count >3+ (OR 5.8, 95% CI 1.2--27.4)
ere independently associated with delayed culture conver-
ion (Table 4).
iscussion
egular sputum smear and culture monitoring during anti-
B treatment allows assessment of sputum conversion, an
mportant issue for therapeutic planning and counseling of
B patients,28 especially in countries such as Portugal29 with
n intermediate incidence of TB.In the present study, we independently analyzed smear
nd culture results of patients with pulmonary TB. The
edian times to smear and culture conversion were above
ne month for both groups, although there were wide and
76 P. Caetano Mota et al.
Table 3 Factors related to delayed sputum smear and culture conversiona (univariate analysis).
Delayed smear conversion Delayed culture conversion
n (%) p value n (%) p value
Age (years)
<50 15 (17.9) 0.003 24 (25.0) 0.371
≥50 15 (44.1) 13 (32.5)
Gender
Female 2 (6.9) 0.008 7 (20.6) 0.317
Male 28 (31.5) 30 (29.4)
Unemployment
Yes 14 (29.2) 0.439 19 (38.0) 0.031
No 16 (22.9) 18 (20.9)
Current smoking habits
Yes 21 (30.9) 0.065 25 (33.3) 0.124
No 3 (12.0) 5 (17.9)
HIV positivity
Yes 4 (36.4) 0.468 8 (53.3) 0.028
No 26 (24.3) 29 (24.0)
Weight (kg)
< 60 12 (19.4) 0.082 17 (23.6) 0.228
≥ 60 16 (34.0) 18 (33.3)
Radiological involvement
Unilateral 15 (23.4) 0.613 15 (19.0) 0.005
Bilateral 13 (27.7) 21 (42.0)
Cavitation
Yes 22 (25.0) 0.856 30 (32.6) 0.041
No 8 (26.7) 7 (15.9)
Smear grading
1+/2+ 1 (5.0) 0.010 3 (15.0) 0.078
3+/4+ 25 (34.2) 26 (35.6)
Colony count
1+/2+ 1 (9.1) 0.278 2 (8.7) 0.018
3+/4+ 24 (28.2) 29 (33.7)
Drug susceptibility
Sensible 28 (25.7) 1.000 4 (27.0) 1.000
Resistant > 1 drug 2 (22.2) 3 (30.0)
HIV: human immunodeﬁciency virus.
a Delayed sputum smear and culture conversion: persistent sputum smear and culture positivity at the end of 2 months of anti-TB
treatment.Table 4 Multivariate logistic regression analysis for variables sig
conversion.
Dependent variable Independent variable
Smear conversion Age≥ 50 years
Male gender
Smear grading (3+/4+)
Culture conversion Bilateral radiological involvement
Colony count (3+/4+)niﬁcantly associated with delayed sputum smear and culture
OR 95% CI p value
4.4 1.5--13.3 0.008
10.8 1.3--91.1 0.029
11.7 1.4--100.6 0.025
3.7 1.5--9.0 0.005
5.8 1.2--27.4 0.027
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variable ranges which demonstrate the inﬂuence of different
factors. Current smoking and bacillary load (smear grade and
colony count) were associated with long conversion times
for both examinations. Male gender was associated with
longer smear conversion time and unemployment, bilateral
radiological involvement, and cavitary disease were asso-
ciated with longer culture conversion time. The range of
smear conversion time was greater than the range of culture
conversion time, presumably due to the presence of nonvi-
able bacilli.20,24
Our results indicated delayed smear and culture conver-
sion in 25.4% and 27.2% of TB patients, respectively.
Previous studies have reported varying conversion times
in TB patients, and this variation is due to differences in
geography, baseline smear status, methodologies, and sta-
tistical analysis.6,8--16,18,24,30--32 In the present study, we found
that delayed smear conversion was independently associ-
ated with age older than 50 years, male gender, and higher
pre-treatment smear grade.
Previous studies have shown that lack of smear conver-
sion is more common in older patients,11,15,18,33,34 due to
their increased incidence of physical disabilities, the non-
efﬁcacious bacilli clearance due to decreased immune
response, and delay in seeking diagnosis and care. The
potential role of some comorbidities, such as those affect-
ing anti-TB drug absorption and metabolism, may also play
a role.
Studies of the effect of gender on sputum conversion
are contradictory. In the present study, we found that male
gender was associated with delayed smear conversion. Our
results agree with those of Rekha et al., who speculated that
this was due to the greater prevalence of alcohol consump-
tion and smoking by men.18 In our study, however, we found
no effect of gender on alcohol consumption and smoking
(data not shown).
We found that patients with high pre-treatment smear
grade (3+/4+) were less likely to convert than patients
with low pre-treatment grade (1+/2+). Previous studies have
reported similar results.6,8,11,35 Rieder reported that smear
conversion at 2 months was 90.9%, 77.9%, and 61.7% in
patients with initially weak, moderate, and strong positivity,
respectively.8 Other studies reported that persistent smear
positivity was associated with higher pre-treatment grade
due to the initially high mycobacterial burden.36,37
Our univariate analysis indicated that positive culture
status at 2 months was associated with unemployment,
HIV positivity, bilateral radiological involvement, cavitation,
and higher colony count. However, our multivariate anal-
ysis indicated that only bilateral radiological involvement
and higher colony count were independently associated with
that outcome.
Our data indicated that unemployed TB patients had
higher prevalence rates of current alcohol consumption,
smoking, and HIV positivity (data not shown), so these are
potential confounders. Previous evidence has shown that
active and passive smokers have an increased risk of con-
tracting active TB compared to non-smokers,38--41 but there
is insufﬁcient data on the association between smoking and
outcome variables, such as culture conversion.38--41 Our uni-
variate analysis indicated that HIV positivity was associated
with delayed culture conversion, but HIV status was not sig-
niﬁcant in the multivariate analysis. This is in line with some77
revious studies which have indicated that HIV status does
ot negatively inﬂuence culture conversion, since its positiv-
ty has been associated with lower bacillary load expressed,
s in our study, by a lower prevalence of cavitary disease in
hese patients (data not shown).18,30,33,35,42
Our results indicated that bilateral radiological involve-
ent and higher colony count were independent risk factors
or delayed culture conversion, due to the high baseline
acillary burden of those patients. In contrast with previous
tudies,6,11,24,28 our results indicated no relationship of cav-
tation with delayed smear or culture conversion, although
ts presence has been signiﬁcantly associated with a longer
ime to culture conversion. This discrepancy could be due to
ifferences in methodologies, populations, our small sample
ize, and/or the retrospective design of our study.
In this study, factors inﬂuencing smear and culture
onversion were different. Consequently, we can specu-
ate about the importance of evaluating each mycobacterial
xamination separately. Su et al. performed a prospective
nalysis of 371 TB patients and reported that the predictive
alue of the 2-month smear in culture conversion was limited
ecause it was highly inﬂuenced by clinical factors, such as
nitial smear results, cavitation, rifampicin resistance, mul-
idrug resistant TB strains, and DOT.24 Similarly, not all of
ur patients presented simultaneously with delayed smear
nd culture conversion.
Knowledge of the risk factors associated with delayed
ulture conversion assists identiﬁcation of the highly infec-
ious patients who require the most medical resources and
rolonged respiratory isolation, and necessitates a cautious
nterpretation of sputum smear results. Consequently, some
uthors22,24 advocate use of a new measure, such as a
iomarker with high accuracy and short yield time, rather
han culture results, for assessment of treatment response
nd infectivity during anti-TB treatment.
The main limitations of the present study are the small
ample size and its retrospective design, with the con-
equent data missing and subjective evaluation of some
eatures. The authors tried to minimize these limitations by
areful review of all clinical ﬁles and available examination
esults.
In conclusion, our analysis showed delayed smear and
ulture conversion in about one third of patients. Older
ge, male gender, and higher bacillary load were indepen-
ently associated with delayed smear conversion; bilateral
adiological involvement and higher colony count were inde-
endently associated with delayed culture conversion. We
uggest that intensiﬁed treatment and precautions against
ransmission should be especially considered for TB patients
ith these risk factors, allowing the optimization of national
B control measures.
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